Dynavax Technologies Corp (DVAX)
11.66
-0.10
(-0.89%)
USD |
NASDAQ |
May 08, 16:00
11.50
-0.16
(-1.33%)
After-Hours: 20:00
Dynavax Technologies Price: 11.66 for May 8, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 07, 2024 | 11.62 | 11.88 | 11.60 | 11.76 | 1.876M |
May 06, 2024 | 11.73 | 11.80 | 11.53 | 11.64 | 1.387M |
May 03, 2024 | 11.87 | 12.06 | 11.71 | 11.74 | 1.817M |
May 02, 2024 | 11.70 | 11.83 | 11.52 | 11.72 | 1.760M |
May 01, 2024 | 11.43 | 12.06 | 11.39 | 11.68 | 2.464M |
Apr 30, 2024 | 11.33 | 11.44 | 11.24 | 11.37 | 1.342M |
Apr 29, 2024 | 11.28 | 11.40 | 11.24 | 11.34 | 1.205M |
Apr 26, 2024 | 11.11 | 11.26 | 11.03 | 11.21 | 1.876M |
Apr 25, 2024 | 11.41 | 11.41 | 11.10 | 11.17 | 1.921M |
Apr 24, 2024 | 11.70 | 11.75 | 11.35 | 11.42 | 1.455M |
Apr 23, 2024 | 11.87 | 12.08 | 11.70 | 11.76 | 1.444M |
Apr 22, 2024 | 11.83 | 12.01 | 11.72 | 11.84 | 2.576M |
Apr 19, 2024 | 11.30 | 11.86 | 11.25 | 11.80 | 9.290M |
Apr 18, 2024 | 11.32 | 11.37 | 11.21 | 11.34 | 2.181M |
Apr 17, 2024 | 11.56 | 11.56 | 11.34 | 11.43 | 2.550M |
Apr 16, 2024 | 11.61 | 11.62 | 11.47 | 11.49 | 2.016M |
Apr 15, 2024 | 11.72 | 11.86 | 11.55 | 11.69 | 1.902M |
Apr 12, 2024 | 12.01 | 12.02 | 11.76 | 11.84 | 1.941M |
Apr 11, 2024 | 12.03 | 12.11 | 11.88 | 12.01 | 1.208M |
Apr 10, 2024 | 11.91 | 12.03 | 11.80 | 11.95 | 1.808M |
Apr 09, 2024 | 11.98 | 12.06 | 11.95 | 12.02 | 1.424M |
Apr 08, 2024 | 12.03 | 12.10 | 11.90 | 12.05 | 907535.0 |
Apr 05, 2024 | 12.07 | 12.17 | 11.92 | 12.05 | 1.134M |
Apr 04, 2024 | 12.17 | 12.39 | 12.04 | 12.08 | 1.377M |
Apr 03, 2024 | 12.24 | 12.34 | 12.12 | 12.19 | 1.249M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.27
Minimum
Mar 16 2020
20.94
Maximum
Nov 03 2021
9.796
Average
10.39
Median
Jun 13 2022
Price Benchmarks
Supernus Pharmaceuticals Inc | 31.32 |
Esperion Therapeutics Inc | 2.035 |
Deciphera Pharmaceuticals Inc | 25.36 |
Ligand Pharmaceuticals Inc | 80.30 |
Pacira BioSciences Inc | 29.58 |
Price Related Metrics
PS Ratio | 7.070 |
Price to Book Value | 2.447 |
Price to Free Cash Flow | 17.03 |
Earnings Yield | -0.51% |
Market Cap | 1.522B |
Normalized PE Ratio | 1067.50 |